This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period
- Takashi Kadowaki, Kazuoki Kondo, Noriyuki Sasaki, Kyoko Miyayama, Shoko Yokota, Ryuji Terata, Maki Gouda
- Expert Opinion on Pharmacotherapy, August 2017, Taylor & Francis
- DOI: 10.1080/14656566.2017.1359259
